Loading...
XSTOAINO
Market cap3mUSD
Dec 23, Last price  
0.30SEK
1D
112.01%
1Q
91.08%
Jan 2017
-98.78%
IPO
-98.56%
Name

Aino Health AB (publ)

Chart & Performance

D1W1MN
XSTO:AINO chart
P/E
—
P/S
1.50
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
42.96%
Rev. gr., 5y
2.88%
Revenues
24m
+20.15%
17,496,00022,252,0005,532,00019,252,00020,754,00025,873,00024,916,00023,044,00019,908,00023,919,000
Net income
-11m
L-30.62%
-913,0001,463,000-5,991,000-31,790,000-22,006,000-15,276,000-12,771,000-16,522,000-15,367,000-10,661,000
CFO
-6m
L-51.36%
-1,171,000198,000-3,001,000-25,887,000-16,269,000-10,776,000-12,069,000-8,113,000-12,873,000-6,261,000
Earnings
Feb 21, 2025

Profile

Aino Health AB (publ) provides corporate health management solutions for private and public organizations in Finland. It offers HealthManager, a software as a service solution that provides surveys, analytics, exposure checks, and security and GDPR services; and e-learning platform. The company also provides telemedicine services; professional services, including analytics, management and employee support, and well-being services; onboarding services, such as project management and planning, implementation, and training and communication services; and other services to occupational health care providers, insurance companies, IT software and service companies, HR, payroll service centers, nurses, online therapists, etc. Aino Health AB (publ) is based in Stockholm, Sweden.
URL
https://ainohealth.com/
IPO date
Dec 16, 2016
Employees
22
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
23,919
20.15%
19,908
-13.61%
23,044
-7.51%
Cost of revenue
21,084
3,099
15,526
Unusual Expense (Income)
NOPBT
2,835
16,809
7,518
NOPBT Margin
11.85%
84.43%
32.62%
Operating Taxes
405
1,302
Tax Rate
2.41%
17.32%
NOPAT
2,835
16,404
6,216
Net income
(10,661)
-30.62%
(15,367)
-6.99%
(16,522)
29.37%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,081
10,000
BB yield
-5.97%
-11.85%
Debt
Debt current
Long-term debt
164
659
1,061
Deferred revenue
Other long-term liabilities
(659)
(1,061)
Net debt
(1,271)
(1,544)
(705)
Cash flow
Cash from operating activities
(6,261)
(12,873)
(8,113)
CAPEX
Cash from investing activities
1,322
Cash from financing activities
5,572
13,193
(450)
FCF
(282)
18,726
15,968
Balance
Cash
1,435
2,158
453
Long term investments
45
1,313
Excess cash
239
1,208
614
Stockholders' equity
(87,004)
(14,166)
(14,714)
Invested Capital
86,317
12,591
18,352
ROIC
5.73%
106.03%
46.51%
ROCE
206.65%
EV
Common stock shares outstanding
125,791
47,275
30,774
Price
0.41
-77.03%
1.79
132.42%
0.77
-65.71%
Market cap
51,574
-38.88%
84,386
257.05%
23,634
-50.81%
EV
50,303
160,734
86,010
EBITDA
5,835
19,683
10,314
EV/EBITDA
8.62
8.17
8.34
Interest
1,095
796
1,302
Interest/NOPBT
38.62%
4.74%
17.32%